These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2987235)

  • 1. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
    Gupta RS; Chopra A
    J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
    Chopra A; Gupta RS
    J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis).
    Gupta RS; Chopra A; Stetsko DK
    J Cell Physiol; 1986 May; 127(2):197-206. PubMed ID: 3009493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cell mutants affected in the interaction of the 12 beta-OH group of cardiac glycosides with the digitalis receptor.
    Gupta RS; Chopra A
    Biochem Pharmacol; 1987 Nov; 36(22):3829-33. PubMed ID: 2825704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance and biochemical characteristics of second-step mutants of HeLa cells resistant to cardiac glycosides.
    Chopra A; Dudani AK; Gupta RS
    Biochem Cell Biol; 1990 May; 68(5):852-7. PubMed ID: 2169261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a specific assay for cardiac glycoside-like compounds based on cross-resistance of human cell mutants.
    Gupta RS; Chopra A; Trott AB
    Biochem Pharmacol; 1989 Jul; 38(13):2159-68. PubMed ID: 2735954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of gene amplification in human cell mutants resistant to cardiac glycosides.
    Dudani AK; Gupta RS
    Mol Cell Biochem; 1987 Nov; 78(1):73-9. PubMed ID: 2457797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by digoxin and SC4453 of (Na+ + K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain.
    Godfraind T; Tona Lutete DN
    Eur J Pharmacol; 1979 Dec; 60(4):329-36. PubMed ID: 230981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an amino acid substitution in human alpha 1 Na,K-ATPase which confers differentially reduced affinity for two related cardiac glycosides.
    Askew GR; Lingrel JB
    J Biol Chem; 1994 Sep; 269(39):24120-6. PubMed ID: 7929066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
    Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant HeLa cells selected for their resistance to ouabain.
    Rosenberg HM
    J Cell Physiol; 1975 Feb; 85(1):135-42. PubMed ID: 1110260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High sensitivity of the Na+, K+-pump of human red blood cells to genins of cardiac glycosides.
    Senn N; Lelièvre LG; Braquet P; Garay R
    Br J Pharmacol; 1988 Apr; 93(4):803-10. PubMed ID: 3390651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutants of HeLa cells resistant to ouabain and cassaine: genetic evidence for the common site of action of cardiac glycosides and erythrophleum alkaloids.
    Gupta RS
    Biochem Pharmacol; 1981 Nov; 30(22):3039-44. PubMed ID: 7337720
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
    Cherniavsky Lev M; Karlish SJ; Garty H
    Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of digoxin and SC4453 with the (Na+ + K+)-ATPase from guinea-pig heart and brain.
    Godfraind T; Tona Lutete N
    Arch Int Pharmacodyn Ther; 1979 May; 239(1):171-2. PubMed ID: 226021
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
    Haustein KO; Graumann G; Stephan B
    Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
    Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
    Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation.
    Dostanic-Larson I; Van Huysse JW; Lorenz JN; Lingrel JB
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15845-50. PubMed ID: 16243970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac glycosides. 6. Gitoxigenin C16 acetates, formates, methoxycarbonates, and digitoxosides. Synthesis and Na+,K+-ATPase inhibitory activities.
    Hashimoto T; Rathore H; Satoh D; Hong G; Griffin JF; From AH; Ahmed K; Fullerton DS
    J Med Chem; 1986 Jun; 29(6):997-1003. PubMed ID: 3012087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.